Clinical Trials
Phase 3 Trial of Rova T as Second-line Therapy...
AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine (Rova-T)...
Articles
The importance of biometric functions to improving data quality...
Reducing the costs associated with clinical trials is one of the pharmaceutical industry’s core challenges. Running a clinical trial is incredibly expensive and if a...
Articles
How implementing electronic clinical outcome assessments (eCOA) into Oncology...
Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial physical and psychosocial consequences of the disease and its treatment...
Clinical Trials
AstraZeneca provides update on the Phase III MYSTIC trial...
AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the Phase III MYSTIC trial. ...
Clinical Trials
Pharm-Olam is proud to have contributed to the execution...
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, extends its congratulations to...
Clinical Trials
REGENXBIO Announces Additional Positive Interim Phase I Trial Update...
REGENXBIO Inc. a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform,...
Clinical Trials
Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility...
Quotient Sciences, a leading drug development services organization, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.